pd168393 has been researched along with dinitrofluorobenzene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, YL; Pui, NN | 1 |
1 other study(ies) available for pd168393 and dinitrofluorobenzene
Article | Year |
---|---|
Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemokine CCL2; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; ErbB Receptors; Forkhead Transcription Factors; Histone Deacetylase Inhibitors; Immunosuppressive Agents; Injections, Intraperitoneal; Male; Mast Cells; Mice; Mice, Inbred BALB C; Phenylbutyrates; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Skin; Stem Cell Factor; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Time Factors; Tumor Necrosis Factor-alpha | 2011 |